Literature DB >> 21499210

Analysis of the human pancreatic stellate cell secreted proteome.

Angela Y Wehr1, Emma E Furth, Vineet Sangar, Ian A Blair, Kenneth H Yu.   

Abstract

OBJECTIVE: Pancreatic stellate cells (PSCs) are important players in pancreatic fibrosis and are major contributors to the extracellular matrix proteins observed with the stromal response characteristic of pancreatic ductal adenocarcinoma (PDAC). Pancreatic stellate cells are also believed to secrete soluble factors that promote tumor progression; however, no comprehensive analysis of the PSC proteome in either the quiescent or the activated state has been reported.
METHODS: Using 2-dimensional tandem mass spectrometry and the RLT-PSC cell line, we present the first comprehensive study describing and comparing the quiescent and activated human PSC-secreted proteomes.
RESULTS: Very few proteins are secreted in the quiescent state. In stark contrast, activated PSCs secreted a vast array of proteins. Many of these proteins differed from those secreted by PDAC-derived cell lines. Proteins associated with wound healing, proliferation, apoptosis, fibrosis, and invasion were characterized. Selected proteins were verified in human tissue samples from PDAC, dysplastic pancreas, and normal pancreas using Western blot analysis and immunohistochemical staining.
CONCLUSIONS: Our study represents the first comprehensive analysis of proteins secreted by PSCs. These findings lay the foundation for characterizing PSC-derived proteins involved in stroma-tumor interactions and the promotion of pancreatitis and PDAC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499210      PMCID: PMC3086313          DOI: 10.1097/MPA.0b013e318214efaf

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  60 in total

1.  Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay.

Authors:  Wilhelm Schneiderhan; Fredy Diaz; Martin Fundel; Shaoxia Zhou; Marco Siech; Cornelia Hasel; Peter Möller; Jürgen E Gschwend; Thomas Seufferlein; Thomas Gress; Guido Adler; Max G Bachem
Journal:  J Cell Sci       Date:  2007-01-16       Impact factor: 5.285

2.  High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma.

Authors:  Ross Smith; AiQun Xue; Anthony Gill; Christopher Scarlett; Alexander Saxby; Adele Clarkson; Thomas Hugh
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

3.  Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.

Authors:  Jun Yu; Qian Tao; Kin F Cheung; Hongchuan Jin; Fan Fong Poon; Xian Wang; Hongyu Li; Yuen Y Cheng; Christoph Röcken; Matthias P A Ebert; Anthony T C Chan; Joseph J Y Sung
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

Review 4.  Nm23-H1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis.

Authors:  BuHyun Youn; Hag Dong Kim; Joon Kim
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

Review 5.  Pancreatic stellate cells--role in pancreas cancer.

Authors:  Max G Bachem; Shaoxia Zhou; Karin Buck; Wilhelm Schneiderhan; Marco Siech
Journal:  Langenbecks Arch Surg       Date:  2008-01-17       Impact factor: 3.445

6.  Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors.

Authors:  Sergey V Ivanov; Alla V Ivanova; Konstantin Salnikow; Olga Timofeeva; Malayannan Subramaniam; Michael I Lerman
Journal:  Biochem Biophys Res Commun       Date:  2008-03-24       Impact factor: 3.575

Review 7.  The functions of UCH-L1 and its relation to neurodegenerative diseases.

Authors:  Rieko Setsuie; Keiji Wada
Journal:  Neurochem Int       Date:  2007-05-24       Impact factor: 3.921

8.  The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration.

Authors:  Masanao Murakami; Patricio I Meneses; Ke Lan; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2008-05       Impact factor: 4.742

9.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression.

Authors:  Rosa F Hwang; Todd Moore; Thiruvengadam Arumugam; Vijaya Ramachandran; Keith D Amos; Armando Rivera; Baoan Ji; Douglas B Evans; Craig D Logsdon
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

10.  Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis.

Authors:  Christoph W Michalski; Andre Gorbachevski; Mert Erkan; Carolin Reiser; Stefanie Deucker; Frank Bergmann; Thomas Giese; Markus Weigand; Nathalia A Giese; Helmut Friess; Jörg Kleeff
Journal:  J Transl Med       Date:  2007-12-05       Impact factor: 5.531

View more
  46 in total

1.  Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.

Authors:  Angela Y Wehr; Wei-Ting Hwang; Ian A Blair; Kenneth H Yu
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

2.  Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS).

Authors:  Joao A Paulo; Raul Urrutia; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  J Proteomics       Date:  2011-09-25       Impact factor: 4.044

Review 3.  Screening and detection of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.

Authors:  Tamas A Gonda; Aimee Lucas; Muhammad Wasif Saif
Journal:  JOP       Date:  2011-07-08

4.  Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence.

Authors:  Md Nazir Hossen; Geeta Rao; Anindya Dey; J David Robertson; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  ACS Appl Mater Interfaces       Date:  2019-07-11       Impact factor: 9.229

5.  A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.

Authors:  Cole R Drifka; Kevin W Eliceiri; Sharon M Weber; W John Kao
Journal:  Lab Chip       Date:  2013-10-07       Impact factor: 6.799

Review 6.  The pancreas cancer microenvironment.

Authors:  Christine Feig; Aarthi Gopinathan; Albrecht Neesse; Derek S Chan; Natalie Cook; David A Tuveson
Journal:  Clin Cancer Res       Date:  2012-08-15       Impact factor: 12.531

7.  Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.

Authors:  Sulagna Banerjee; Shrey Modi; Olivia McGinn; Xianda Zhao; Vikas Dudeja; Sundaram Ramakrishnan; Ashok K Saluja
Journal:  Clin Cancer Res       Date:  2015-09-24       Impact factor: 12.531

8.  Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle.

Authors:  Shaunagh McDermott; Sarah P Thayer; Carlos Fernandez-Del Castillo; Mari Mino-Kenudson; Ralph Weissleder; Mukesh G Harisinghani
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 9.  Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.

Authors:  Michael Friberg Bruun Nielsen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

10.  Evolution of novel therapeutic options for pancreatic cancer.

Authors:  Ashok K Saluja; Vikas Dudeja; Sulagna Banerjee
Journal:  Curr Opin Gastroenterol       Date:  2016-09       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.